DxPx is a World Series of Industry & Investor Partnering Conferences.
We focus on Diagnostics, Digital Health,
Precision Medicine & Life Science Tools.

The founders of DxPx are all startup entrepreneurs and former industry executives.
This conference was born to fill a gap. To answer a need. To help you change the future of our industries.
Learn More
One-to-One Meetings with Investors, C-level Executives and renowned Industry Speakers await!

Promoting startups and growth companies is the heart and soul of DxPx.

Meet hundreds of investors; where else would you find the opportunity
to pack 20 pitch meetings in one day?
While most people will talk the talk, few will walk the walk;
be amongst those few.
Join Dxpx
Win $2,000,000 funding.

Not only our finalists, but every Start-Up and Growth Company,
can benefit from the attendion of the jurors.
Apply now and reap the benefits before even attending the event!
All finalists, get free tickets for the DxPx Conference.
Everyone attending the conference, benefits from immense networking.
The winning businesses... SKY-ROCKET.
Apply Now
Ready?
Have you already realized that attending the DxPx Conference
is an immense opportunity to grow?
(or candidly inquisitive enough to want to review the pricing?)
Get your ticket

join. network. Grow.

With the gaining importance of diagnostics, digital health, precision medicine and life science tools there is a need for a dedicated platform to bring together the relevant stakeholders
and further drive our industries. 

Days
Hours
Minutes
Seconds

On November 16th, 2021, parallel to MEDICA, the World Forum for Medicine, the DxPx Conference will bring together startups and growth companies as well as established industry companies and investors to a diagnostics, digital health, precision medicine and life science tools partnering conference.

The DxPx Conference Series:

The paramount importance of diagnostics, digital health, precision medicine and life science tools, dictate the need for a dedicated platform. DxPx brings together the relevant stakeholders
and further drives our industries.
DxPx is hosted as an annual international partnering conference to facilitate licensing, financing, co-development and M&A opportunities and celebrates great success and fast growth.

At a Glance:

Date: November 16th, 2021.
Place: Düsseldorf.
Open for: Start-Ups, Growth Companies,
established industry companies and investors
Online: 8 days digital partnering Nov 12th – 20th, 2021
Learn More

Network & Grow:

"Being a part of a Start-Up
is like trying to build a bike, while riding it."


You know that, we know that, and "smart people" know that:
You have to learn from the mistakes of others.

We are here to help.

Your Next Steps:

Secure your DxPx ticket.
Submit your pitch to 42PLUS1.
Showcase your business with a DxPx exhibition booth.


Whatever you're thinking, think bigger.
Join DxPx

2 million Reasons to Apply:

You are right; by "reasons" we mean Dollars.

Building your own company is exciting. It needs a lot of hard work, faith in yourself and in your team, a mind-blowing vision
as well as sufficient funding.

Apply for the 42PLUS1 Pitch Award.
Claim the attention of the jurors and free tickets.

Finding Funding:

Everyone loves a play-on-words.
You think your vision can shake the world's,
the world's market, life and needs?
We found a lock; you got the keys?
Unlock Funding

Ready?!

If you know what to expect, why procrastinate?

One ticket unlocks a myriad of opportunities.
100s of Start-Ups, Growth Companies,
Investors & Industry Partners
join DxPx every year.

Tailor-made Offers for:

Technology Transfer Offices & Press
Investors & Industry Leaders
Startups & Growth Companies
and more:
Get Your Ticket

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience